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ABSTRACT: We followed the course of canine parvovirus (CPV) antibody prevalence in a
subpopulation of wolves (Canis lupus) in northeastern Minnesota from 1973, when antibodies
were first detected, through 2004. Annual early pup survival was reduced by 70%, and wolf
population change was related to CPV antibody prevalence. In the greater Minnesota population
of 3,000 wolves, pup survival was reduced by 40–60%. This reduction limited the Minnesota wolf
population rate of increase to about 4% per year compared with increases of 16–58% in other
populations. Because it is young wolves that disperse, reduced pup survival may have caused
reduced dispersal and reduced recolonization of new range in Minnesota.
Key words: Canine parvovirus (CPV), demography, dispersal, population, wolf.
INTRODUCTION
Canine parvovirus (CPV) may have
originated from a feline panleukopenia-
like virus in a wild carnivore (Steinel et al.,
2001). The earliest evidence of CPV
infection in a canine species comes from
the detection of CPV antibodies in wild
wolves (Canis lupus) that were sampled in
northeastern Minnesota during 1973
(Mech and Goyal, 1995). Antibodies to
CPV subsequently were detected in do-
mestic dogs (Canis lupus familiaris) in
Greece in 1974 (Koptopoulos et al., 1986)
and from dogs in the Netherlands in 1976
(Schwers et al., 1979). The virus has been
detected in wild and domestic canids
worldwide (Steinel et al., 2001).
Mortality related to CPV in domestic
canids primarily is associated with younger
animals (1–12 wk old; Eugster and Nairn,
1977; Meunier et al., 1981), but almost
nothing is known about the epidemiology
of CPV in wild canid populations or its
potential to impact populations negatively.
The disease can be fatal to wolves (Mech
et al., 1986; 1997) and is suspected to have
caused declines or attenuation of wolf
populations in Wisconsin (Wydeven et al.,
1995) and on Isle Royale, Michigan
(Peterson et al., 1998). In a small area
(2%) of Minnesota’s wolf range, wolf
population changes were highly related
(r250.83) to CPV antibody prevalence
from 1984 through 1993 (Mech and
Goyal, 1995). Now, after following the
course of CPV infection in wolves in that
study area (intensive study area [ISA];
48uN latitude and 91u159W longitude)
since the first appearance of CPV some
30 yr ago, we document its long-term
effect in the ISA and demonstrate its
effect on the entire Minnesota wolf
population of some 3,000 animals over
an 88,325-km2 range.
Our data consist of the following: 1) an
annual antibody prevalence of CPV in
wolves in our ISA from 1973 through
2004, 2) an index of annual wolf
pup survival to 4 mo of age in the ISA,
3) an annual winter census of wolves in the
ISA from 1972 through 2004, 4) intermit-
tent CPV antibody prevalence estimates in
wolves in the total Minnesota wolf range
from 1979 to 2004, 5) an index of annual
pup survival to 4 mo in the entire
Minnesota wolf range from 1979 to 2004,
and 6) histories of CPV antibody status
in wolves sampled multiple times in the
ISA.
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MATERIALS AND METHODS
Study area
The ISA is a 2,060-km2 part of the Superior
National Forest northeast of Ely, Minnesota
(Fig. 1). The wolf population on the ISA is
part of the much larger Minnesota wolf
population that represents the southernmost
extension of the Canadian wolf population,
and has never been exterminated. Humans
and dogs inhabit the western and southern
edges of the ISA, and the entire area is used
for recreation. The wolves feed primarily on
white-tailed deer (Odocoileus virginianus),
moose (Alces alces), and beavers (Castor
canadensis). The Minnesota wolf range
(Fig. 1) occupies the northeastern 40% of
Minnesota, including wilderness and semiwil-
derness forest interspersed with farms, towns,
and cities. Dispersing and nomadic wolves
travel throughout this range and into neigh-
boring Ontario, Manitoba, Wisconsin, and
Michigan.
Wolf demography
We live-trapped wolves (Mech, 1974) from
May to October or November in the ISA and
the immediately adjacent area. In the greater
Minnesota wolf range, we trapped and eutha-
nized wolves as part of a government depre-
dation-control program. We distinguished wolf
pups from adults by the presence of milk
canine teeth (Van Ballenberghe and Mech,
1975). We also attached radio collars to most
of the wolves captured in the ISA (Mech,
1974) and later located them from a fixed-wing
FIGURE 1. The study areas. Minnesota wolf range is lined. The intensive study area (ISA) is black, and the
Superior National Forest is gray.
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aircraft. We aerially observed radio-tagged
wolves and their packmates throughout each
winter and counted all members of each pack
in the census area. Numbers presented here
represent the maximum observed members
per radioed pack during December–January
each year supplemented by tracks or observa-
tions of nonradioed packs whose territories fell
wholly or partly in the census area (Mech,
1986). Annual changes in estimated popula-
tions were related to annual changes in mean
size of radioed packs (r250.35; P,0.01),
which were error-free knowns. We were able
to obtain some information on pup litter size in
our ISA by aerially observing radioed wolves
with pups near their dens in late spring and
summer. Because of poor visibility, these
counts only represented minimum pup num-
bers.
Serology
We weighed, examined, and sexed each wolf
caught and collected blood, which was pro-
cessed for CPV antibodies as described below.
We removed serum from blood samples and
stored it at 215 C to 220 C until assaying for
CPV antibody by the hemagglutination inhibi-
tion (HI) test (Carmichael et al., 1980). Sera
were heat activated, treated with 25% kaolin,
and absorbed with packed porcine erythro-
cytes to remove nonspecific hemagglutinins.
We mixed serial twofold dilutions of sera in 96-
well microtiter plates with eight hemaggluti-
nation units of CPV and incubated them at
4 C overnight. A 1% suspension of porcine
erythrocytes was added, and after 2 hr of
incubation at 4 C the test was read. Antibody
titer represented the reciprocal of highest
serum dilution that completely inhibited
hemagglutination; titers of $256 were consid-
ered positive. The HI test has not been
validated in wolves and the CPV strain used
in the test was derived from dogs; it is not
known how close that strain is to CPV strains
infecting wolves. Our positive threshold titer
of $256 was conservative; titers of 128 are
considered positive for CPV antibodies in dogs
(Carmichael and Binn, 1981). We considered
the percentage of wolves that were positive on
their first capture as the antibody prevalence
for that year (Goyal et al., 1986; Mech et al.,
1986). Data from recaptured and retested
wolves were counted in our antibody preva-
lence analyses only during the wolves’ first
year of capture and testing.
Simple linear and polynomial regression
were used to relate trends in antibody
prevalence with year, percent of pups caught,
and percent annual changes in the wolf
population, and chi-square tests were used to
compare antibody prevalence among ages, sex,
study areas, and years. Changes in CPV
antibody prevalence were monitored over time
for periodicity by comparing nine models
under an information-theoretic model selec-
tion approach (Burnham and Anderson, 2002).
We posed a set of nine plausible models to
describe the observed trajectory of CPV
antibody prevalence in the ISA (Table 1).
Model 1 (Table 1) is a simple linear regres-
sion, model 2 is a quadratic regression, model
3 is a logistic growth model, and models 4–9
are combined logistic growth models with
various trigonometric transformations with
parameter P an estimate of period (Graybill,
1976). We used the PROC NLIN of SAS (SAS
Institute Inc., 2004) to fit all models with the
default Gauss–Newton iterative method to
compute parameter estimates. Akaike’s infor-
mation criteria for small samples (AICc) was
used to determine which models best described
the trajectory. This modeling effort is descrip-
tive only, with no implications beyond the years
of this study or to other wolf populations. Our
goal was to determine how much evidence
there is for periodicity in the nonlinear,
increasing seroprevalence trajectory.
RESULTS
Intensive study area
Wolves were live-trapped (Mech, 1974)
and bled (n5542 wolves) in the ISA area
TABLE 1. Summary of plausible models examined
for modeling canine parvovirus prevalence in wolves
from 1972 to 2004. The response variable (y) is the
percentage of sampled wolves with canine
parvovirus, year (t) is the explanatory variable
(rescaled to year—1972). The number of
parameters (k) includes one for the residual
variance parameter s2 (p53.14).
Model
no. Model structure k
1 y5bt 2
2 y5b1t+b2t2 3
3 y5a(12exp(bt)) 3
4 y5a(12exp(bt))+d cos(2pt/P) 5
5 y5a(12exp(bt))+c sin(2pt/P) 5
6 y5a(12exp(bt))+d cos(2pt/P)
+c sin(2pt/P)
6
7 y5a(12exp(bt))+c/(t+1) sin(2pt/P) 5
8 y5a(12exp(bt))+d/(t+1) cos(2pt/P) 5
9 y5a(12exp(bt))+d/(t+1) cos(2pt/P)
+c/(t+1) sin(2pt/P)
6
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from 1972 through 2004. Some of the
wolves were captured multiple times, and
hence 720 samples were tested for CPV
antibody (Mech and Goyal, 1995). From
1973 through 2004, 9–30 (mean516)
wolves (total5518) were serologically test-
ed per year during their first capture
(Table 2). We recaptured and CPV-tested
54 females and 44 males two–nine times
each over intervals of 2 days to 5.9 yr, for a
total of 175 capture/recapture pairs. Of
those, 49 involved 36 individual pups.
We captured 233 different pups during
290 pup captures, but not all were CPV-
antibody tested. Pups comprised 8–70% of
the wolves captured each year. Radio-
tagged wolves inhabited 4–10 (mean56.8)
packs of 2–15 wolves per year (Mech,
1986, and unpublished data).
Five of nine wolves captured in 1973
tested positive for CPV (titer5256) and
five of 11 in 1974 (titers5256–2,048). The
earliest CPV-positive wolf, and the first
animal of any species anywhere docu-
TABLE 2. Data on canine parvovirus (CPV) effect on measures of wolf population change in an intensive
2,060-km2 study area of northeastern Minnesota.
Year na % CPV % pups Populationb % changeb
No. packs radioed
this year and next
X¯ pack size
Radioed pack size
changebThis year Next year
1973c 9 56 67 65 27 5 6.2 3.0 252
1974 11 45 44 44 232 7 3.7 5.0 35
1975 16 35 41 56 27 7 6.6 5.1 222
1976 15 40 50 45 220 5 5.8 5.6 23
1977 18 11d 67 50 11 4 4.5 2.5 244
1978 12 8 10 46 28 3 3.3 3.7 10
1979 15 20 44 54 17 4 3.3 3.0 28
1980 23 73 48 48 211 5 4.0 3.4 215
1981 19 53 43 47 22 6 5.7 5.2 29
1982 18 44 53 50 6 4 6.5 5.0 223
1983 14 36 50 35 230 5 2.6 4.8 85
1984 14 21 70 54 54 6 5.2 5.5 6
1985 18 44 45 47 213 7 5.7 4.4 223
1986 11 64 25 48 2 5 3.8 4.6 21
1987 25 36 28 59 23 5 4.6 8.2 78
1988 21 14 42 79 34 3 8.7 7.0 219
1989 17 100 11 51 235 3 7.0 4.0 243
1990 30 60 20 56 10 6 4.2 6.0 44
1991 26 46 46 53 25 6 6.0 6.5 8
1992 17 47 47 55 3 5 7.0 7.6 9
1993 20 65 25 55 0 5 8.6 7.6 212
1994 14 57 7 55 0 3 7.7 8.7 13
1995 16 56 44 69 25 4 7.5 7.3 23
1996 11 73 6 56 219 7 7.6 6.1 219
1997 28 64 40 55 22 8 5.0 4.4 213
1998 11 55 40 50 29 7 4.9 4.3 213
1999 9 67 25 44 212 6 4.7 4.8 0
2000 18 72 28 52 18 6 5.2 5.0 23
2001 9 78 0 53 2 6 4.7 5.2 11
2002 8 80 10 58 9 7 4.0 4.9 21
2003 14 64 7 62 7 7 5.3 7.9 49
2004 11 82 21 74 19
a n 5 wolves tested for CPV on their first capture; recaptured are only counted once.
b The following winter.
c The only wolves tested in 1972 (n52) had CPV titers of 64 and 128.
d X253.72; P50.05; df51 for 1976 versus 1977 and X253.48; P50.06; df51 for 1976 versus 1978.
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mented with CPV antibodies, was male
wolf 5053 sampled on 18 May 1973 in
eastern Lake County. Four other wolves
from two–three other packs captured
within 18 km of where wolf 5053 was
trapped and within the next 5 mo also
tested antibody positive (titer5256). Five
other wolves sampled in the same area
during the same period tested negative
(titer5128).
Of the 720 CPV tests (including recap-
tures) in the ISA, 335 (46.5%) were
negative (titers 0–128) and 385 (53.5%)
were positive (titers 256–8,192; Table 3).
Of 350 males tested, 183 (52%) were
positive and 167 were negative. Of the 370
females, 201 (49%) were positive and 169
were negative; prevalence differences
between genders were not statistically
significant. Fifty-four (25%) pups tested
positive and 165 negative versus 330
adults positive and 171 adults negative, a
significant difference between adults and
pups (P,0.01; X25103.98, df51). For
both adults and pups, almost equal
proportions of males and females were
positive.
CPV-antibody prevalence (adults and
pups) increased in this population through
2004 (Table 2), with evidence of period-
icity of 7.33 (SE50.3) yr and dwindling
amplitude (Fig. 2). Table 4 presents the
TABLE 3. Canine parvovirus (CPV) titers for 518
wolves tested and retested (720 wolf tests) in the
Superior National Forest (SNF) from 1972 through
2004 and 221 wolves tested throughout Minnesota
from 1979 to 2004.
CPV
SNF Minnesota
N % N %
Negative 54 7.5 – –
7 ,1.0 4 1.8
8 23 3.1 4 1.8
16 35 4.9 15 6.8
32 80 11.1 20 9.0
64 68 9.4 17 7.7
128 68 9.4 17 7.7
256 94 13.1 17 7.7
512 112 15.6 36 16.3
1,024 111 15.4 47 21.3
2,048 54 7.5 37 16.7
4,096 13 1.8 6 2.7
8,192 1 ,1.0 1 ,1.0
FIGURE 2. Canine parvovirus (CPV) seroprevalence in adult and pups (.2 mo old) in the Superior
National Forest of northeastern Minnesota compared with a logistic growth model (dashed line) with sine
transformation (adjusted R250.85).
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number of parameters in each of the nine
models, the residual sum of squares,
computed AICc, DAICc (models sorted
by), Akaike model weights, and adjusted
R2 values. Four models (models 1, 2, 3,
and 7) had DAICC values ,4.0, with the
remaining models offering less evidence of
plausibility. Models 1, 2, and 3 indicated
an increase in CPV with the latter two
models accounting for the nonlinearity in
the trajectory. The inclusion of model 7 in
this set of plausible models provides
evidence of periodicity.
Some recaptured wolves seroconverted
over short periods. Adult male 6041 had a
titer of 128 on 6 September 1983 and 512
on 9 September; female pup 17 had a titer
of 16 on August 7, 1987 and 1,024 on 19
August. The proportion of wolf recaptures
converting from negative to positive or
retaining their positive status increased
with time (Fig. 3). Of the 44 male and 54
female wolves tested 2–9 times over
periods of up to 5.9 yr, 62% of the
recaptures either seroconverted or re-
mained positive, 29% remained negative,
and one (9%) converted from positive to
negative. Some wolves failed to serocon-
vert over long periods. Of the 83 male
recaptures, six (7%) failed to seroconvert
over periods of $1 year, including one
after 1,753 days. Of the 92 female
recaptures, eight (9%) failed to serocon-
vert over periods of $1 yr, including one
TABLE 4. Results of an information-theoretic approach for assessment of models from Table 1 (model
numbers are from Table 1 and are sorted by Akaike’s information criteria [DAICc]). RSS5residual sum of
squares, total sum of squares510.2275 for all models, n533 yr.
Model no. k RSS AICc DAICc Weight Adjusted R
2
1 2 1.5760 222.23 0.00 0.4071 0.79
3 3 1.2677 221.59 0.64 0.2961 0.81
2 3 1.3271 221.00 1.23 0.2199 0.81
7 5 0.7468 218.57 3.66 0.0652 0.85
4 5 1.1327 213.15 9.10 0.0044 0.78
5 5 1.1894 212.52 9.71 0.0032 0.77
8 5 1.2361 212.02 10.21 0.0025 0.76
9 6 0.7462 211.15 11.08 0.0016 0.82
6 6 1.1325 23 16.50 0.0001 0.73
FIGURE 3. Progression of changes in canine parvovirus (CPV) seroprevalence in wolves tested multiple
times in the Superior National Forest of northeastern Minnesota. PP (n552) 5 positive ($256) to positive;
NP (n521) 5 negative to positive; PN (n512) 5 positive to negative; NN (n535) 5 negative to negative.
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after 2,139 days. However, all except one
of these recaptured animals were tested
before 1986. Six (14%) of the male and
nine (17%) of the female recaptures
converted from positive to negative and
these cases were spread over the entire
study period. One female and one male
seroconverted from negative to positive
and back to negative, and one female and
one male converted from positive to
negative and back to positive.
Nine (25%) of 36 wolves first caught
and CPV tested as pups from 1975 to 1998
were positive on retest. Six (17%) of them
retained positive status upon recapture 2
days to 3.1 yr later. Within 1 yr, nine
(25%) had seroconverted, and by 4 yr,
50% had seroconverted.
The primary effect of CPV in the ISA
wolf population could have been mortality
of pups ,3 mo old (Eugster and Nairn,
1977; Meunier et al., 1981; Johnson et al.,
1994), as this would have removed them
from our sample. Pups in our area are
usually born about 25 April, and first
appear outside the den 3 wk later. We
were able to observe three CPV-positive
(256–1,024) females (one during 2 yr)
with litter sizes of four–six pups (mean
5.4 pups/litter). The earliest we caught a
seropositive pup was on 13 July 1997.
However, this male pup weighed 15 kg,
which is heavy for an 11-wk-old pup; the
pup may have been born early. We radio-
collared most pups .5-mo-old, so we
were able to document their survival after
that and often their cause of death. We
documented the death of a 9-mo-old
female from CPV infection (Mech et al.,
1997).
Pups 3–7 mo old comprised 0–70% of
wolves live-trapped each year (Table 2); the
proportion of pups in the total sample
significantly declined curvilinearly through-
out the study (r250.33; P50.01) (Fig. 4).
The decline began in about 1984 after CPV
became enzootic in the population (Mech
and Goyal, 1995) and was inversely related
to CPV antibody prevalence from 1984 to
2004 (r250.51; P,0.01). The annual per-
cent change in the wolf population from
winter 1984–1985 to winter 2004–2005 was
in turn directly related to the proportion of
pups caught during the previous summer
(r250.22; P50.03) and inversely related to
CPV antibody prevalence (r250.38;
P,0.01). A related but more conservative
(error-free) component of annual wolf
population change, annual change in size
of radio-tagged wolf packs, was also related
to CPV antibody prevalence (r250.35;
P,0.01).
FIGURE 4. Trend in wolf-pup survival index in Superior National Forest of northeastern
Minnesota (P50.01).
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The greater Minnesota wolf population
In the Minnesota wolf population at
large, from 1979 through 2004, we cap-
tured 2,562 wolves in 16 counties and
tested 221 for CPV antibodies from 1979
to 1989, and in 1991, 1992, and 2004.
Sixty-five percent were positive, signifi-
cantly higher than the percent in the ISA
(X259.38; P,0.01; df51). Annual CPV
antibody prevalence increased with time
from 17% to 100% in 2004 (r250.24;
P50.13). CPV-antibody prevalence in
eight counties varied from 33% to 85%
with samples of six to 39 wolves per
county. Three contiguous counties in
extreme northwestern Minnesota had the
highest antibody prevalence (69%, 75%,
and 85%). Beltrami County had a signif-
icantly higher antibody prevalence than all
other counties (X254.06–11.49; P50.04–
0.01; df51) with the exception of two
neighboring counties; Lake of the Woods
and Roseau Counties (Fig. 1).
Twenty-four percent (n5668) of the
wolves captured in greater Minnesota
were pups (range 5–67%/year). The per-
cent of pups captured each year declined
(r250.46; P,0.01) curvilinearly (Fig. 5).
The mean proportion of pups captured
from 1979 through 1984 was 40, whereas
from 1985 through 2004 it was 21
(P50.01). The Minnesota wolf population
increased at an average annual rate of 3.0–
4.5% from 1979 to 2004 (Fuller et al.,
1992; Berg and Benson, 1999; Erb and
Benson, 2004).
History of CPV
One of the earliest locations where CPV
appeared (the earliest on record) was in
our northeastern Minnesota ISA. The area
where we captured the first antibody-
positive wolves is wilderness, but it
contains gravel roads and canoe routes
and is frequented by humans and dogs.
The CPV status of wolves before 1973 is
not known. We sampled only two wolves
in 1972, neither of which was positive,
although one had an antibody titer of 128,
which some consider positive (Carmichael
and Binn, 1981). In May 1973 we
captured the first of five CPV-positive
(titer5256) wolves.
CPV-antibody prevalence remained at
38–45% through 1976 in wolves from the
same immediate area that we sampled in
1973, and then it dropped significantly
(X253.48–3.72; P50.05–0.06; df51) in
FIGURE 5. Trend in wolf-pup survival index in statewide Minnesota population (P,0.01).
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1977 and 1978. In addition, wolf 353
(positive at a titer of 256) in November
1975 tested negative in June and August
1977 (titers58 and 64, respectively) but
wolf 5472, which was positive (titer5512)
in October 1976 remained positive (ti-
ter51,024) in September 1978. Three
other wolves that were negative (ti-
ters564–128) in 1977 remained negative
(titers516–128) in 1978. If foci of CPV
infection were still localized in 1977 and
1978, the decreased antibody prevalence
might have resulted from bias in area
sampled. However, by 1976, we had found
CPV-positive wolves 16 km north of the
1973 locations and 26 km west, and our
1977 and 1978 samples included those
areas and areas in between, so biased
sampling probably was not the cause of
the temporary decline in seroprevalence.
In any case, in adult ISA wolves, CPV-
antibody prevalence increased (r250.47;
P,0.01) and from 1985 through 2004, it
averaged 81%. In 3–7-mo-old ISA pups,
however, CPV seroprevalence averaged
43% from 1973 through 1982 (n572), but
as increasingly fewer pups survived and
entered our sample (Fig. 4), CPV sero-
prevalence in pups dropped to 12% from
1983 through 2004 (n5119; X2524.39;
P,0.01, df51).
DISCUSSION
The apparent cyclicity and dwindling
amplitude of CPV-antibody prevalence in
our ISA appears to be a unique observa-
tion for a long study of a wildlife disease.
In a 14-yr study of canine distemper in
raccoons (Procyon lotor), epizootics oc-
curred at 4-yr intervals but incidence did
not vary during these events (Roscoe,
1993). The Akaike weight model 7 is not
strong compared to models 1, 2, and 3, but
the adjusted R2 value indicates a good fit
to the trajectory (Table 4). Although the
evidence is not overwhelming, model 7
indicates a periodicity of 7.33 (SE50.32)
yr (Table 5). We note that model 7
includes structure that accounts for not
only the period parameter P but also for
the dampening of the fluctuation in the
trajectory.
As CPV was infecting wolves in our ISA
(Mech et al., 1986), it also began to be
detected elsewhere. CPV-antibody-posi-
tive dogs were documented in Greece in
1974 (Koptopoulos et al., 1986), in the
Netherlands in 1976 (Schwers et al.,
1979), and in Texas in 1977 (Eugster and
Nairn, 1977). In 1979, one of the three
wolves sampled in Koochiching County in
the main Minnesota population was pos-
itive (titer51,024), some 160 km west of
our ISA, and in 1980, antibody prevalence
in 19 wolves was 53%, with positive
animals in Roseau County in northwestern
Minnesota 275 km from our ISA.
CPV effect on wolves
We believe that the primary effect of
CPV in our study is mortality in young
pups. The only other way of explaining a
TABLE 5. Parameter estimates, approximate standard errors (SE), and approximate 95% confidence
intervals for models 1, 3, 2, and 7 from Table 1.
Model Parameter Estimate Approximate SE Approximate 95% confidence intervals
1 b 0.0275 0.0021 (0.0233, 0.0317)
3 a 0.7379 0.1275 (0.4779, 0.9980)
b 20.0860 0.0369 (20.1612, 20.0107)
2 b1 0.0456 0.0077 (0.0298, 0.0614)
b2 20.0007 0.0003 (20.0014, 20.0001)
7 a 0.7662 0.1203 (0.5202, 1.0122)
b 20.0766 0.0276 (20.1332, 20.0201)
c 1.2072 0.2684 (0.6584, 1.7561)
P 7.330 0.3171 (6.6814, 7.9786)
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link between increased CPV-antibody
prevalence and decreased number of pups
would be through a CPV effect on litter
size of CPV-positive adult females. How-
ever, the mean litter size of our CPV-
positive females (5.4 pups) compares
favorably with the normal litter size of
6.0 (Mech, 1970). Although about 10% of
the wolves we captured and followed in
our ISA had CPV titers $2,048, only one
(9 mo old) wolf died from CPV. In
beagles, CPV titers reached $1,280 only
in individuals within 2 wk of active infec-
tion (Hirasawa et al., 1987). Apparently
most of our wolves $3 mo old were able
to survive infections.
Mortality related to CPV primarily
occurs in 1–12-wk-old animals (Eugster
and Nairn, 1977; Meunier et al., 1981;
Johnson et al., 1994), although CPV
mortality has been reported in 15-mo-old
captive wolves (Goyal et al., 1986). Ma-
ternal antibodies in coyotes (Canis la-
trans) have been reported in 83% of pups
of antibody-positive mothers and can
persist for up to 8 wk (Green et al.,
1984). Titers of maternally derived anti-
bodies in dog pups in large litters were
lower than in small litters (Pollock and
Carmichael, 1982), but after 8–12 wk such
pups were no longer protected (Meunier
et al., 1981). In coyote pups, the half life of
maternally derived CPV antibody was 6.7
days (Green et al., 1984) and in dogs, 9.7
days (Pollock and Carmichael, 1982). Thus
wolf pups, without maternal antibodies,
would become vulnerable to CPV when
they emerge from the den at about 3 wk of
age; pups with maternal antibodies would
become susceptible after 6–8 wk.
Canine parvovirus may be maintained
in the ISA wolf population by carrier
animals. A dog with an HI titer of 4 at
6 mo postinfection, shed virus in feces for
$6 mo (Komolafe, 1985); CPV can re-
main infective in feces $7 mo (Gordon
and Angrick, 1986). It is possible that the
virus can remain infective in wolf feces for
#5 yr (Muneer et al., 1988). Antibodies in
dogs persisted $2 yr (Carmichael and
Binn, 1981). One of our wolves (female
5176) had positive titers all five times
tested from 1975 through 1983. Our
recapture data indicated that seroconver-
sion can take place within 3–12 days and
25% of recaptured pups had seroconvert-
ed within a year.
Because wolf pups remain close to dens
until $12 wk old (about July 25), our
sampling technique, which depended on
animals traveling, included few pups that
were vulnerable to CPV. Therefore, the
proportion of pups in our capture sample
became an inverse index to pup survival.
This index (i.e., pup survival) declined in
our ISA (Mech et al., 1986), especially
after CPV became enzootic in the ISA
about 1984 (Mech and Goyal, 1995). An
additional 11 yr of data from the ISA and
an examination of this pup index in the
wolf population at large now indicate that
CPV has affected not only the local wolf
population in the ISA, but also the entire
Minnesota wolf population. The number
of pups now surviving through summer
each year has been reduced from the pre-
CPV period by about 70% in the ISA and
by 40–60% in the entire Minnesota wolf
population. Although this drastic decline
in pup survival does influence annual
population change, as documented above
in our ISA, enough pups still survive to
maintain the population. This is because
competition for food is keen in this
saturated population, and pup starvation
(Van Ballenberghe and Mech, 1975) and
other types of mortality are high (Mech,
1977). Thus, much of CPV-caused mor-
tality merely compensates for other causes
of death (Mech and Goyal, 1995).
Population effects of CPV
In a population with the potential to
colonize additional areas, the 40–60% pup
reduction can seriously retard further
colonization. A high proportion of surviv-
ing pups disperse from their natal packs
when 1–3 yr old (Mech and Boitani,
2003), seek new areas with adequate prey,
mate, reproduce, and form new packs,
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thus expanding the population. The main
prey of wolves in most of Minnesota is
white-tailed deer, and although in low
density in the ISA, they abound in most of
Minnesota. There, the pre-CPV level of
pup production would have led to in-
creased dispersal and colonization of new
areas similar to adjacent Wisconsin and
Michigan, where wolves are increasing at
many times Minnesota’s rate (Fuller et al.,
1992; Wydeven et al., 1995). Although the
growth of the Wisconsin wolf population
apparently was retarded by CPV early in
its recolonization (Wydeven et al., 1995), it
has since flourished. From 1981 through
1986, the nascent Wisconsin wolf popula-
tion dropped from 21 to 16 individuals
when its CPV antibody prevalence was
77% (24/31) whereas from 1988 to 1996 it
increased an average of 18% per year from
26 to 99 wolves when CPV seroprevalence
was down to 35% (22/63) (X2515.02;
P50.01; df51; Wisconsin Department of
Natural Resources, 1999).
The known effects of CPV on young
pups, our data on litter sizes, as well as our
correlations and the lack of other plausible
explanations, suggest that CPV caused the
demographic changes we observed. In
2004, CPV antibody prevalence in greater
Minnesota was 100% (n517), and from
1997 through 2004 antibody prevalence in
ISA adults averaged 87% (72 of 83
animals).
A recent report that CPV antibody
prevalence in Yellowstone National Park
(YNP) wolves was 100% from 1995 to 2005
(Smith and Almberg, 2007) raises the
question of why the CPV antibody preva-
lence in our area has fluctuated. One
explanation is that the YNP wolves are
highly isolated from any possible source of
non-exposed immigrants. The ISA, con-
versely, adjoins the entire Canadian wolf
population, so it receives immigration from
pristine wilderness areas where CPV may
not yet have become established. Wolves
can disperse straight-line distances of up to
1,092 km (Wabakken et al., 2007).
We still do not understand, however,
what determines the spatial variation in
CPV antibody prevalence in Minnesota
wolves. While CPV was spreading through
Minnesota, the prevalence was the highest
in the extreme northwest. That area
receives less precipitation, mostly
,60 cm/yr, whereas most of the rest of
Minnesota wolf range receives 66–81 cm/
yr (Spatial Climate Analysis Service,
2000). Transmission can occur through
contact with infected feces, and dry feces
can remain positive for CPV for more than
5 yr (Muneer et al., 1988). Higher precip-
itation would serve to remove fecal
material; the lower precipitation in north-
western Minnesota may explain the higher
CPV antibody prevalence there. A higher
precipitation of 76–86 cm/yr in Wiscon-
sin’s wolf range (Spatial Climate Analysis
Service, 2000) also may explain why CPV
is more sporadic there and has not
become endemic in the wolf population.
One final question our study raises
involves the origin of CPV. Although
much is known about the molecular
changes that allowed the feline panleuko-
penia-like virus to spread to canids
(Shackleton et al., 2005), it is not known
where and when that mutation occurred.
The initial evidence of this virus in canids,
specifically from wolves in northeastern
Minnesota in 1973, supports the idea that
wild canids may have been involved in this
adaptation.
This study appears to be the first to
document compelling, circumstantial evi-
dence for long-term effects of CPV on a
wildlife population and the only investiga-
tion that has followed the course of any
wildlife disease from near its inception
through its first 30 yr. We conclude, from
our ISA data, from the greater Minnesota
data, and from the Wisconsin data, that
there is compelling circumstantial evi-
dence that CPV may be a major determi-
nant of rate of wolf population increase
and recolonization over its current range
in the midwestern USA and that it is
restricting further recolonization of Min-
nesota.
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